Position in AXGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$794,424
-$1,240,923 QoQ
Shares Held
23,979
-61.4% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026BRADLEY FOSTER & SARGENT INC/CT holds $144,231,355 across 9 Medical Devices names. AXGN ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
611,016 | $62,733,012 | |
| 2 | BSX |
Boston Scientific Corp
|
627,470 | $39,373,742 | |
| 3 | SYK |
Stryker Corp
|
91,975 | $30,222,065 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
96,678 | $6,881,540 | |
| 5 | MDT |
Medtronic plc
|
26,150 | $2,265,897 | |
| 6 | EW |
Edwards Lifesciences Corp
|
14,169 | $1,134,653 | |
| 7 | AXGN |
Axogen, Inc.
This page
|
23,979 | $794,424 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
6,250 | $565,125 |
All Filings in AXGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $794,424 | 23,979 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,035,347 | 62,186 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,109,398 | 62,186 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $674,718 | 62,186 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,191,492 | 64,405 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,386,841 | 84,153 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,137,919 | 81,164 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||